CorAssist is a Pre-clinical stage medical device company committed to developing innovative therapeutic products for treating diastolic heart failure. The company's proprietary technology enables the first implantation of a device that directly improves cardiac diastolic function. The company's first product, the ImCardia, is an elastic self-expanding device that is attached to the external left ventricular surface, through a simple off-pump closed heart procedure. The device assists diastolic function through reduction of filling pressures, and does not require an external power source.
CEO: Amir Loshakove
Evergreen Partner: Ronit Bendori